Saneyoshi et al.
2′-O-(2-Cyanoethyl)-5′-O-(4,4′-dimethoxytrityl)-
uridine (5a). Compound 4a (1.97 g, 6.63 mmol) was coevapo-
rated five times with dry toluene and finally dissolved in dry
pyridine (70 mL). To the solution was added 4,4′-dimethoxy-
trityl chloride (2.47 g, 7.29 mmol). After being stirred at room
temperature for 4 h, the mixture was quenched by addition of
water and evaporated in vacuo. The residue was dissolved with
CHCl3. The solution was washed with brine and aqueous
NaHCO3. The organic layer was dried over Na2SO4 and
concentrated in vacuo. The residue was chromatographed on
a column of silica gel with CHCl3-MeOH (95:5, v/v) containing
0.5% triethylamine to give compound 5a as white foam (3.91
g, 98%): 1H NMR (CDCl3, 500 MHz) δ 2.68-2.71 (2 H, m),
3.53-3.58 (2 H, m), 3.90-3.98 (2 H, m), 4.03-4.06 (1 H, m),
4.17-4.22 (1 H, m), 4.49 (1 H, dd, J ) 5.1, 8.8), 5.31 (1 H, d,
J ) 8.1), 5.89 (1 H, s), 6.84-6.86 (4H, m), 7.21-7.40 (9H, m),
8.06 (1 H, d, J ) 8.1); 13C NMR (CDCl3) δ 19.0, 55.3, 60.8,
65.4, 68.2, 83.0, 87.1, 87.8, 102.3, 113.4, 117.7, 127.2, 128.1,
128.2, 130.1, 130.2, 135.1, 135.3, 139.8, 144.4, 150.7, 158.7,
158.8, 163.9; HRMS calcd for C33H33N3O8 (M + Na+) 622.2165,
found 622.2162.
Loading of 2′-O-(2-Cyanoethyl)uridine on CPG Resin.
Compound 5a (180 mg, 0.30 mmol) was dissolved in dry CH2-
Cl2 (30 mL). To the solution were added 4-(dimethylamino)-
pyridine (48 mg, 0.39 mmol) and succinic anhydride (60 mg,
0.60 mmol). After being stirred at room temperature for 20 h,
the mixture was washed with aqueous 10% citric acid and H2O.
The organic layer was dried over Na2SO4 and concentrated in
vacuo. The residue was chromatographed on a column of silica
gel with CHCl3-MeOH (90:10, v/v) to give the 3′-O-succinate
as white foam (151 mg, 73%): 1H NMR (CDCl3, 500 MHz) δ
2.38-2.42 (1 H, m), 2.51-2.55 (1 H, m), 2.54-2.93 (4 H, m),
3.38 (1 H, dd, J ) 2.0, 11.7), 3.75-3.80 (7 H, m), 3.90-3.94 (1
H, m), 4.02-4.06 (1 H, m), 4.38-4.41 (1 H, m), 5.13 (1H, dd,
J ) 4.9, 9.8), 5.32 (1 H, dd, J ) 1.7, 8.1), 5.79 (1 H, s), 6.81-
6.85 (4H, m), 7.22-7.38 (9H, m), 8.21 (1 H, d, J ) 8.1), 11.17
(1H, br); 13C NMR (CDCl3) δ 19.4, 28.0, 28.2, 55.4, 59.9, 67.2,
68.5, 80.1, 81.7, 87.4, 89.7, 101.0, 113.4, 113.5, 118.7, 127.3,
128.2, 130.3, 135.1, 140.8, 144.3, 149.4, 158.9, 166.7, 172.0,
177.4.
An LCAA CPG resin (500 mg, 101.9 µmol/g) was suspended
in CH2Cl2 (5 mL). To the solution were added 3′-O-succinate
(18 mg, 26 µmol) and DCC (16 mg, 78 µmol). After being stirred
at room temperature for 15 h, the resin was filtered and
washed with dry CH2Cl2 and dry CH3CN. To the resin was
added a capping solution (pyridine-Ac2O, 9:1, v/v) in advance
and stirred at room temperature for 12 h. The resin was
washed with dry CH2Cl2 and dry CH3CN and dried in vacuo.
The amount of Uce loaded to the solid support was calculated
to be 16 µmol/g from calculation of the released dimethoxytrityl
cation by use of a solution of 60% HClO4-EtOH (3:2, v/v).
2-Cyanoethyl 2′-O-(2-Cyanoethyl)-5′-O-(4,4′-dimeth-
oxytrityl)uridine 3′-(N,N-Diisopropyl)phosphoramidite
(6a). Compound 5a (1.20 g, 2.00 mmol) was coevaporated 5
times with dry toluene and dissolved in dry CH2Cl2 (10 mL)
under argon atmosphere. To the solution were added ethyl-
diisopropylamine (0.5 mL, 2.87 mmol) and a solution of chloro-
(2-cyanoethoxy)(N,N-diisopropylamino)phosphine (521 mg, 2.20
mmol) in dry CH2Cl2 (2 mL). After being stirred at room
temperature for 2 h, the mixture was diluted with CHCl3. The
solution was washed with brine and aqueous NaHCO3. The
organic layer was dried over Na2SO4 and filtered. The solution
was evaporated in vacuo. The residue was chromatographed
on a column of silica gel with CHCl3-MeOH (98:2, v/v)
containing 0.5% triethylamine to give compound 6a as white
foam (1.33 g, 83%): 1H NMR CDCl3, 500 MHz) δ 1.11-1.29
(12 H, m), 2.42-2.73 (4 H, m), 3.42-4.66 (16 H, m), 5.19-
5.26 (1 H, m), 5.87-5.88 (1 H, m), 6.82-6.87 (4 H, m), 7.23-
7.43 (9 H, m), 8.05-8.11 (1 H, m); 13C NMR (CDCl3) δ 19.0,
19.1, 20.6, 20.7, 22.0, 22.8, 23.1, 24.6, 24.7, 24.8, 43.3, 43.4,
45.4, 55.4, 58.0, 59.4, 60.5, 65.6, 65.9, 69.0, 69.7, 69.8, 80.5,
80.6, 81.7, 82.3, 82.8, 87.2, 88.9, 89.2, 102.2, 102.3, 113.4, 113.5,
117.8, 118.1, 127.3, 127.5, 128.1, 128.2, 128.4, 130.4, 134.7,
135.1, 135.2, 139.4, 139.9, 143.81, 144.3, 150.3, 150.4, 158.8,
158.9, 159.0, 163.3, 163.4; 31P NMR (CDCl3) δ 151.1, 150.0;
HRMS calcd for C42H50N5O9P (M + H+) 800.3424, found
800.3419
Oligonucleotide Synthesis. Oligoribonucleotides were
synthesized on an Applied Biosystems 392 oligonucleotide
synthesizer on a 1 µmol, using 2′-O-cyanoethylated phosphor-
amidite building blocks 6a-6d and/or 2′-O-TBDMS PAC
phosphoramidites (PacA, isopropyl-PAC-G, and Acetyl-C) from
Glen Research. A 0.1 M solution of each 2′-O-Ce or 2′-O-
TBDMS nucleoside phosphoramidite was used, and the time
for coupling time was set to be 10 min. 1H-Tetrazole (0.45 M;
for fully 2′-O-cyanoethylated RNA) and 5-ethylthio-1H-tetra-
zole (0.25 M; for one point modified RNAs) were used as the
activator. Deprotection was carried out by use of ammonium
hydroxide at room temperature for 20 min (for fully 2′-O-
cyanoethylated oligouridylate), NH4OH-NH4OAc (10:1, w/w)
at room temperature for 90 min (for fully cyanoethylated RNAs
containing U, C, A, and G), propylamine-THF (1:1, v/v) at 40
°C for 24 h, and Et3N‚3HF at room temperature for 24 h (one-
point modified RNAs).
The products were analyzed after C18 cartridge purification
by use of anion-exchange HPLC as shown in Figure 2
(chromatographic conditions: a linear gradient of 25 mM
sodium phosphate buffer containing 1 M NaCl (pH 6.0), 0-50%
for 50 min, in 25 mM sodium phosphate buffer, pH 6.0, at a
flow rate of 1 mL/min at 50 °C). The pure materials of the
following oligoribonucleotides were obtained after additional
reversed-phase HPLC (chromatographic conditions: a linear
gradient of acetonitrile, 0-30% for 30 min, in 100 mM
ammonium acetate, pH 7.0, at a flow rate of 1 mL/min at 50
°C) for UceU or anion-exchange HPLC for the other oligo-
nucleotides in the following yields. UceU (80%), (Uce)12 (21%),
GceAceCceUce
(58%),
GceAceCceUceGceAceCceUce-
GceAceCceUce (6%), GCUAGceACUAUCUA (10%), GCUA-
GAceCUAUCUA (12%), GCUAGACceUAUCUA (13%), GC-
UAGACUceAUCUA (14%), GAGCCAceAGCIUCGGCUC (33%).
Nuclease Resistance Assay. The nuclease stability of the
2′-O-cyanoethylated oligonucleotides was evaluated by treat-
ment with snake venom phosphodiesterase (Purchased from
Sigma) or bovine spleen phosphodiesterase (Purchased from
Sigma). The enzyme assay using snake venom phosphodi-
esterase (5 × 10-4 u/mL) was performed in a buffer of 50 mM
Tris-HCl at pH 8.5, 72 mM NaCl and 14 mM MgCl2 at 37 °C
by use of 50 µM oligonucleotide. The enzyme assay using
bovine spleen phosphodiesterase (0.2 U/mL) was performed
in a buffer 30 mM NaOAc at pH 6.0 at 37 °C by use of 50 µM
oligonucleotide. After the enzyme was deactivated by heating
at 100 °C for 2 min, the solution was diluted and filtered by a
0.45-µm filter (Millex-HV, Millipore). The mixture was ana-
lyzed by reverse-phase HPLC or anion exchange HPLC.
Acknowledgment. This work was supported by a
Grant from CREST of JST (Japan Science and Technol-
ogy Agency) and a Grant-in-Aid for Scientific Research
from the Ministry of Education, Culture, Sports, Science
and Technology, Japan. This work was also supported
by the COE21 project. This work was supported in part
by a grant of the Genome Network Project from the
Ministry of Education, Culture, Sports, Science and
Technology, Japan.
Supporting Information Available: General procedure
and the procedures for the synthesis of 2′-O-cyanoethylated
adenosine, guanosine, cytidine, and their phosphoroamidites.
1H NMR, 13C NMR, and 31P NMR spectra of all new com-
pounds. This material is available free of charge via the
JO051741R
10460 J. Org. Chem., Vol. 70, No. 25, 2005